Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06719180 · ClinicalTrials.gov registry record · Phase 4
Vaginal Cuff Anesthesia and Post-Operative Pain Medication Use
A Phase 4 study of Hysterectomy and Post Operative Analgesia, sponsored by MediSys Health Network.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06719180: Recruiting Phase 4 study of Hysterectomy and Post Operative Analgesia, sponsored by MediSys Health Network.
NCT06719180 is a Phase 4 study of Hysterectomy and Post Operative Analgesia that is actively recruiting participants, run by MediSys Health Network. The registered enrollment target is 100 participants, below the 127-participant average among 8 other Hysterectomy trials with a reported enrollment target (21% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06719180, a Phase 4 study of Hysterectomy and Post Operative Analgesia, is actively recruiting participants, sponsored by MediSys Health Network.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether an injection of a local anesthetic (Bupivacaine with epinephrine) in the vaginal cuff prior to closure would result in less immediate postoperative pain medication and increase patient comfort/satisfaction.
Conditions Studied
Interventions
- DRUG Bupivacain
- OTHER Saline (NaCl 0,9 %) (placebo)
Study Locations (1)
New York
- Flushing Hospital Medical Center - Flushing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-12-01 |
| Est. Completion | 2025-10-31 |
| Phase | Phase 4 |
What NCT06719180 shows while recruiting
NCT06719180 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 127-participant average among 8 other Hysterectomy trials with a reported enrollment target (21% lower).
The record links to 2 conditions, with Hysterectomy appearing as the primary indexed condition, and to 2 interventions - of which Bupivacain is the first listed.
NCT06719180 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06719180 about?
NCT06719180 is a clinical study titled "Vaginal Cuff Anesthesia and Post-Operative Pain Medication Use". The purpose of this study is to determine whether an injection of a local anesthetic (Bupivacaine with epinephrine) in the vaginal cuff prior to closure would result in less immediate postoperative pain medication and increase patient comfort/satisfaction.
What is the current status of trial NCT06719180?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2024-12-01. Estimated completion is 2025-10-31.
What conditions does trial NCT06719180 study?
This clinical trial studies the following conditions: Hysterectomy, Post Operative Analgesia.
What interventions are being tested in trial NCT06719180?
The interventions under investigation include: Bupivacain (DRUG), Saline (NaCl 0,9 %) (placebo) (OTHER).
Who is sponsoring clinical trial NCT06719180?
This trial is sponsored by MediSys Health Network, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06719180 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hysterectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06719180's enrollment target sits among peer trials
100 4th of 8 higher than 4 of 8 other Hysterectomy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hysterectomy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mixture of Liposomal Bupivacaine and Bupivacaine for TAP Block for Open Hysterectomy
COMPLETED · Phase 4
-
NAC vs Placebo on Opioid Use for Hysterectomy
RECRUITING · Phase 3
-
Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy
RECRUITING · Phase 3
-
Bilateral Oophorectomy Versus Ovarian Conservation
COMPLETED · NA
-
Ultravision Visual Clearing System in Laparoscopic Hysterectomy and Myomectomy
COMPLETED · NA
-
Urinary Tract Infections Rates Using 50% Dextrose Plus Washout Versus Normal Saline as Cystoscopy Fluid
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI